Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01743651 |
|
Recruitment Status :
Completed
First Posted : December 6, 2012
Last Update Posted : April 25, 2022
|
Sponsor:
RVL Pharmaceuticals, Inc.
Collaborator:
Osmotica Pharmaceutical US LLC
Information provided by (Responsible Party):
RVL Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 2014 |
| Actual Study Completion Date : | April 2014 |
| Certification/Extension First Submitted : | January 9, 2020 |